Patent details
EP1797892
Title:
Use of modified cyclosporins for the treatment of HCV disorders
Basic Information
- Publication number:
- EP1797892
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP061256491
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Use of modified cyclosporins for the treatment of HCV disorders
- French Title of Invention:
- Utilisation de cyclosporines modifiées pour le traitement de maladies liées au virus de l'hépatite C (HCV)
- German Title of Invention:
- Verwendung von modifizierten Cyclosporinen zur Behandlung von HCV Krankheiten
- SPC Number:
-
Dates
- Filing date:
- 02/09/2004
- Grant date:
- 23/10/2013
- EP Publication Date:
- 23/10/2013
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/06/2007
- EP B1 Publication Date:
- 23/10/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 02/09/2014
- Expiration date:
- 02/09/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/09/2004
-
-
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- Shimotohno Kunitada
- Address:
- Japan (JP)
2
- Name:
- Watashi Koichi
- Address:
- Japan (JP)
3
- Name:
- Hijikata Makoto
- Address:
- Japan (JP)
Priority
- Priority Number:
- 0320638
- Priority Date:
- 03/09/2003
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
-
A61K 38/13;
Filing date |
Document type |
Number of pages |